{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus Panels",
        "MicroScan MICroSTREP plus with Moxifloxacin"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K111205",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "JWY",
        "LTW"
    ],
    "Summary Letter Date": "July 14, 2011",
    "Summary Letter Received Date": "July 15, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Moxifloxacin"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of aerobic streptococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Manual read",
        "Automated read (WalkAway instrument)"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panels with Moxifloxacin for antimicrobial susceptibility testing of aerobic streptococci.",
    "Indications for Use Summary": "Determines quantitative and/or qualitative antimicrobial agent susceptibility of colonies of aerobic streptococci, including Streptococcus pneumoniae, using Moxifloxacin at concentrations of 0.03 to 8 \u00b5g/ml.",
    "fda_folder": "Microbiology"
}